John W. Smither

Insider Reports History

Location
Calabasas, CA
Signature
/s/ Thomas Zindrick, J.D. Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John W. Smither:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcutis Biotherapeutics, Inc. Chief Financial Officer Common Stock 141K $501K $3.54 13 Feb 2024 By Trust
GENELUX Corp Director Common Stock 75K $252K $3.36 27 Aug 2025 Direct
NewAmsterdam Pharma Co N.V. Director Ordinary Shares 6.96K $178K $25.54 07 Jan 2025 Direct
Arcutis Biotherapeutics, Inc. Chief Financial Officer Common Stock 11.4K $40.2K $3.54 13 Feb 2024 Direct
NewAmsterdam Pharma Co N.V. Director Option (right to buy) 32.5K 06 Jan 2025 Direct
GENELUX Corp Director Stock Option (Right to Buy) 28.6K 27 Aug 2025 Direct
eFFECTOR Therapeutics, Inc. Director Stock Option (Right to Buy) 20K 22 Jun 2023 Direct
Applied Molecular Transport Inc. Director Stock Option (Right to Buy) 0 27 Dec 2023 Direct
Arcutis Biotherapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 0 13 Feb 2024 Direct

Insider Reports Filed by John W. Smither

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GNLX GENELUX Corp 27 Aug 2025 2 $0 4 Director 29 Aug 2025, 16:30
NAMS NewAmsterdam Pharma Co N.V. 06 Jan 2025 2 $0 4 Director 08 Jan 2025, 18:09
GNLX GENELUX Corp 01 Aug 2024 1 $0 4/A Director 31 Dec 2024, 13:20
GNLX GENELUX Corp 29 May 2024 2 $0 4 Director 07 Jun 2024, 21:45
ARQT Arcutis Biotherapeutics, Inc. 13 Feb 2024 4 $0 4 Chief Financial Officer 15 Feb 2024, 18:23
NAMS NewAmsterdam Pharma Co N.V. 01 Jan 2024 1 $0 4 Director 03 Jan 2024, 17:13
NAMS NewAmsterdam Pharma Co N.V. 29 Dec 2023 0 $0 3 Director 29 Dec 2023, 16:30
AMTI Applied Molecular Transport Inc. 27 Dec 2023 3 $0 4 Director 28 Dec 2023, 17:38
GNLX GENELUX Corp 13 Sep 2023 1 -$18.7K 4 Director 14 Sep 2023, 21:18
GNLX GENELUX Corp 11 Sep 2023 2 $0 4 Director 13 Sep 2023, 21:14
GNLX GENELUX Corp 11 Sep 2023 0 $0 3 Director 13 Sep 2023, 21:13
ARQT Arcutis Biotherapeutics, Inc. 31 Aug 2023 1 $0 4 Chief Financial Officer 05 Sep 2023, 22:38
ARQT Arcutis Biotherapeutics, Inc. 31 Aug 2023 0 $0 3 Chief Financial Officer 05 Sep 2023, 22:36
EFTR eFFECTOR Therapeutics, Inc. 22 Jun 2023 1 $0 4 Director 22 Jun 2023, 20:16
AMTI Applied Molecular Transport Inc. 14 Jun 2023 1 $0 4 Director 15 Jun 2023, 17:28
EFTR eFFECTOR Therapeutics, Inc. 20 Jan 2023 1 $0 4 Director 24 Jan 2023, 15:15
EFTR eFFECTOR Therapeutics, Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 18:51
AMTI Applied Molecular Transport Inc. 24 May 2022 1 $0 4 Director 26 May 2022, 17:23
AMTI Applied Molecular Transport Inc. 27 Jan 2022 1 $0 4 Director 31 Jan 2022, 16:39
AMTI Applied Molecular Transport Inc. 27 Jan 2022 0 $0 3 Director 31 Jan 2022, 16:38
EFTR eFFECTOR Therapeutics, Inc. 06 Oct 2021 1 $0 4 Director 08 Oct 2021, 17:18
EFTR eFFECTOR Therapeutics, Inc. 25 Aug 2021 3 $0 4 Director 27 Aug 2021, 18:26
EFTR eFFECTOR Therapeutics, Inc. 25 Aug 2020 0 $0 3 Director 27 Aug 2021, 18:24